AAAAAA

   
Results: 1-11 |
Results: 11

Authors: O'Neill, MJ Hicks, CA Ward, MA Osborne, DJ Wishart, G Mathews, KS McLaughlin, DP Stamford, JA McCarty, DR Patrick, KE Roman, C Fleisch, JH Gilmore, J Boot, JR
Citation: Mj. O'Neill et al., LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia, BRAIN RES, 888(1), 2001, pp. 138-149

Authors: O'Neill, MJ Bogaert, L Hicks, CA Bond, A Ward, MA Ebinger, G Ornstein, PL Michotte, Y Lodge, D
Citation: Mj. O'Neill et al., LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia, NEUROPHARM, 39(9), 2000, pp. 1575-1588

Authors: Bond, A Jones, NM Hicks, CA Whiffin, GM Ward, MA O'Neill, MF Kingston, AE Monn, JA Ornstein, PL Schoepp, DD Lodge, D O'Neill, MJ
Citation: A. Bond et al., Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist:Investigations into possible mechanism of action in vivo, J PHARM EXP, 294(3), 2000, pp. 800-809

Authors: Hicks, CA Ward, MA O'Neill, MJ
Citation: Ca. Hicks et al., Neuroprotective effects of the neuronal Ca2+ channel blockers, LY042826 and LY393615 in vivo, EUR J PHARM, 408(3), 2000, pp. 241-248

Authors: O'Neill, MJ Murray, TK McCarty, DR Hicks, CA Dell, CP Patrick, KE Ward, MA Osborne, DJ Wiernicki, TR Roman, CR Lodge, D Fleisch, JH Singh, J
Citation: Mj. O'Neill et al., ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia, BRAIN RES, 871(2), 2000, pp. 234-244

Authors: Bond, A Ragumoorthy, N Monn, JA Hicks, CA Ward, MA Lodge, D O'Neill, MJ
Citation: A. Bond et al., LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia, NEUROSCI L, 273(3), 1999, pp. 191-194

Authors: Hicks, CA Ward, MA Swettenham, JB O'Neill, MJ
Citation: Ca. Hicks et al., Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia, EUR J PHARM, 381(2-3), 1999, pp. 113-119

Authors: Bond, A Lodge, D Hicks, CA Ward, MA O'Neill, MJ
Citation: A. Bond et al., NMDA receptor antagonism, but not AMPA receptor antagonism attenuates induced ischaemic tolerance in the gerbil hippocampus, EUR J PHARM, 380(2-3), 1999, pp. 91-99

Authors: Stamford, JA Isaac, D Hicks, CA Ward, MA Osborne, DJ O'Neill, MJ
Citation: Ja. Stamford et al., Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data, BRAIN RES, 835(2), 1999, pp. 229-240

Authors: Hicks, CA Ward, MA Ragumoorthy, N Ambler, SJ Dell, CP Dobson, D O'Neill, MJ
Citation: Ca. Hicks et al., Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia, BRAIN RES, 819(1-2), 1999, pp. 65-74

Authors: O'Neill, MF Hicks, CA Shaw, G Parameswaran, T Cardwell, GP O'Neill, MJ
Citation: Mf. O'Neill et al., Effects of 5-hydroxytryptamine, receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine, J PHARM EXP, 287(3), 1998, pp. 839-846
Risultati: 1-11 |